Lineage Cell Therapeutics - M&A Summary and Business Overview

Life ScienceCompany

Lineage Cell Therapeutics M&A Summary

Lineage Cell Therapeutics has acquired 1 company, including 1 in the last 5 years.

Lineage Cell Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Lineage Cell Therapeutics Business Overview

Where is Lineage Cell Therapeutics headquartered?

Lineage Cell Therapeutics is headquartered in Carlsbad, California.

What is Lineage Cell Therapeutics’ revenue?

Lineage Cell Therapeutics disclosed revenue of 9M USD for 2023 and 15M USD for 2022.

How many employees does Lineage Cell Therapeutics have?

Lineage Cell Therapeutics has 68 employees.

What sector is Lineage Cell Therapeutics in?

Lineage Cell Therapeutics is a life science company.

When was Lineage Cell Therapeutics founded?

Lineage Cell Therapeutics was founded in 1990.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 2

Lineage Cell Therapeutics

Lineage Cell Therapeutics, Inc.

2173 Salk Avenue, Suite 200,
Carlsbad, California 92008
United States,
(442) 287-8990
www.lineagecell.com

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. BioTime’s programs are based on the Company’s proprietary cell-based therapy platform which is utilized to develop and manufacture specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury, or administered as a means of helping the body mount an effective immune response to cancer. Lineage Cell Therapeutics was founded in 1990 and is based in Carlsbad, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Asterias Biotherapeutics, Inc. 2019-03-11 - Add-on Acquisition
Fremont, California · www.asteriasbiotherapeutics.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  California 1 - - -
Total 1 - - -

Top M&A Advisors

Financial Deals
Maxim Group LLC
1
Legal Deals
Cooley
1

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.